Dr. Stefano Persiani is currently Director of Translational Sciences and Pharmacokinetics at Rottapharm-Madaus, Italy. After gaining his PhD in 1983 from the School of Pharmacy of the University of Milan, Italy and after a one-year scholarship at the National Cancer Institute of Milan, Italy, Dr. Persiani obtained in 1986, a Postdoctoral Fellowship from the University of Pittsburgh, School of Medicine, and the Pittsburgh Cancer Institute. He progressed through academia as Research Associate, in the Dept. of Pharmaceutics, University of Southern California, School of Pharmacy in Los Angeles. In 1990 Dr. Persiani moved to the pharmaceutical industry and CRO sector holding different positions in R&D at Farmitalia Carlo Erba, Pharmacia, Upjon, and Zambon Group until 2000 when he joined Rottapharm. Dr. Persiani experience within pharmaceutical companies and CROs’ ranges from drug discovery and lead optimization to early preclinical and full clinical development in different therapeutic areas including oncology, respiratory, CNS, anti-infective, cardiovascular, gastrointestinal, and rheumatology. Dr. Persiani is an author of more than 100 publications.
PTI is part of the Knowledge & Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.